Ireland· IE-PA-PA23229/010/001
Dolmatil 200mg Tablets
A sulpiride product containing sulpiride, registered in Ireland by Neuraxpharm Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Sulpiride is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Sulpiride · ATC N05AL01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sulpiride costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulpiride · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$1.00
The record
At a glance
HPRA (Ireland)- Active substance
- Sulpiride
- Manufacturer
- Neuraxpharm Ireland Limited
- Country
- Ireland (IE)
- ATC code
- N05AL01
- ATC class
- Sulpiride
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23229/010/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
23 interactions on record for sulpiride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulpiride · interactions on record
23 records
23 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Sulpiride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDolmatil 200mg tabletsSanofi
- CzechiaPROSULPINPRO.MED.CS Praha a.s.
- FranceDOGMATIL 200 mg, comprimé sécableNEURAXPHARM FRANCE
- PolandSulpiryd HascoPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- SwitzerlandDogmatil 200
- SpainDOGMATIL FUERTE 200 mg COMPRIMIDOSNeuraxpharm Spain S.L.U.
- NorwaySulpirid 1a pharma1 A Pharma
- FinlandSupriumNeuraxpharm Sweden AB
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Dogmatil, Sulpirid Grindeks
- Belgium · Dogmatil, Sulpiride Eg
- Cyprus · Devodil, Sulpiren
- Czechia · Dogmatil, Prosulpin
- Germany · Dogmatil, Dogmatil Forte
- Estonia · Betamaks
- Spain · Dogmatil, Dogmatil Fuerte
- Finland · Suprium
- France · Dogmatil, Dogmatil Sans Sucre, Édulcorée Au Cyclamate De Sodium
- United Kingdom (Northern Ireland) · Sulpiride, Sulpiride Activase Pharmaceuticals
- Greece · Dogmatyl
- Croatia · Eglonyl, Eglonyl Forte
- Hungary · Depral
- Italy · Dobren
- Lithuania · Eglonyl
- Luxembourg · Dogmatil, Sulpiride Eg
- Latvia · Betamaks
- Malta · Devodil, Sulpiride Grindeks
- Netherlands · Dogmatil
- Poland · Sulpiryd Hasco, Sulpiryd Teva
- Portugal · Dogmatil, Dogmatil Forte
- Romania · Eglonyl
- Slovenia · Eglonyl
- Slovakia · Betamaks, Sulpirid Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1a4bac1f-63c0-4d8b-9906-7254fa9a29f6 GET /v1/drugs/1a4bac1f-63c0-4d8b-9906-7254fa9a29f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N05AL",
"N05AL01"
],
"strength": null,
"pa_number": "PA23229/010/001",
"substances": [
"Sulpiride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "08/04/1987",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about sulpiride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.